TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Measurement and Treatment of Post-stroke Neglect
Brief Summary: This study examines how to best assess and treat post-stroke neglect. This study will examine the preliminary effects of an innovative intervention (repetitive task-specific practice + transcranial direct current stimulation) for individuals with neglect. This study will also determine whether items from various neglect assessments can be combined to establish a more comprehensive neglect measure.


Options:
A: Arm Label: Intervention-Control (IC); Type: EXPERIMENTAL; Interventions: Behavioral: Optokinetic stimulation and cueing-based reading therapy (OKS-READ), Behavioral: General neuropsychological treatment | Arm Label: Control-Intervention (CI); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Optokinetic stimulation and cueing-based reading therapy (OKS-READ), Behavioral: General neuropsychological treatment | Intervention Type: BEHAVIORAL; Name: Optokinetic stimulation and cueing-based reading therapy (OKS-READ); Assigned to Arm(s): Control-Intervention (CI), Intervention-Control (IC) | Intervention Type: BEHAVIORAL; Name: General neuropsychological treatment; Assigned to Arm(s): Control-Intervention (CI), Intervention-Control (IC)
B: Arm Label: Sham tDCS plus RTP; Type: SHAM_COMPARATOR; Interventions: Device: Sham tDCS | Arm Label: Active tDCS plus RTP; Type: ACTIVE_COMPARATOR; Interventions: Device: Active tDCS | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Sham tDCS plus RTP | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Active tDCS plus RTP
C: Arm Label: Cognitive rehabilitation group; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive rehabilitation training with RGS in the clinic | Arm Label: Passive control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Passive/conventional cognitive training at home. | Intervention Type: BEHAVIORAL; Name: Cognitive rehabilitation training with RGS in the clinic; Assigned to Arm(s): Cognitive rehabilitation group | Intervention Type: BEHAVIORAL; Name: Passive/conventional cognitive training at home.; Assigned to Arm(s): Passive control group
D: Arm Label: High frequency rTMS plus fNIRS; Type: EXPERIMENTAL; Interventions: Device: Functional near infrared spectroscopy, Device: rTMS | Arm Label: Sham rTMS; Type: SHAM_COMPARATOR; Interventions: Device: rTMS | Arm Label: High frequency rTMS; Type: EXPERIMENTAL; Interventions: Device: rTMS | Intervention Type: DEVICE; Name: Functional near infrared spectroscopy; Assigned to Arm(s): High frequency rTMS plus fNIRS | Intervention Type: DEVICE; Name: rTMS; Assigned to Arm(s): High frequency rTMS, High frequency rTMS plus fNIRS, Sham rTMS

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial for Investigating a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease: CardioCare MV
Brief Summary: Cardiovascular diseases are the number 1 cause of death globally and represent a major economic burden on health care systems. The investigators have developed a novel integrated care concept (NICC) which combines telemedicine with intensive support by a call center, an integrated care network including in- and outpatient care providers and guideline therapy for patients with heart failure (HF), atrial fibrillation (AF) or therapy resistant hypertension (TRH). The aim of the study is to show that NICC is preferable over guideline therapy alone. We aim at including approximately 890 patients. Patients could be enrolled either directly at the Care-Center (location: University Hospital of Rostock) or at one of the advanced treatments rooms of the Care-Center (outpatient cardiological specialist practices).

The ethics commission's statement of the University of Rostock is available for amendment 2 since 20.08.2019 at the number A2017-0117.


Options:
A: Arm Label: Nurse Practitioner Led-Care; Type: EXPERIMENTAL; Interventions: Other: Nurse Practitioner Led-Care | Arm Label: Cardiologist Led-Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Cardiologist Led-Care | Intervention Type: OTHER; Name: Nurse Practitioner Led-Care; Assigned to Arm(s): Nurse Practitioner Led-Care | Intervention Type: OTHER; Name: Cardiologist Led-Care; Assigned to Arm(s): Cardiologist Led-Care
B: Arm Label: Immediate Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: risk reduction | Arm Label: Delayed Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: risk reduction | Intervention Type: BEHAVIORAL; Name: risk reduction; Assigned to Arm(s): Delayed Intervention, Immediate Intervention
C: Arm Label: Novel integrated care concept (NICC); Type: EXPERIMENTAL; Interventions: Other: Novel integrated care concept (NICC) | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Novel integrated care concept (NICC); Assigned to Arm(s): Novel integrated care concept (NICC) | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Educational Intervention | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational Intervention; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial for Investigating a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease: CardioCare MV
Brief Summary: Cardiovascular diseases are the number 1 cause of death globally and represent a major economic burden on health care systems. The investigators have developed a novel integrated care concept (NICC) which combines telemedicine with intensive support by a call center, an integrated care network including in- and outpatient care providers and guideline therapy for patients with heart failure (HF), atrial fibrillation (AF) or therapy resistant hypertension (TRH). The aim of the study is to show that NICC is preferable over guideline therapy alone. We aim at including approximately 890 patients. Patients could be enrolled either directly at the Care-Center (location: University Hospital of Rostock) or at one of the advanced treatments rooms of the Care-Center (outpatient cardiological specialist practices).

The ethics commission's statement of the University of Rostock is available for amendment 2 since 20.08.2019 at the number A2017-0117.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: mHealth intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: mHealth intervention; Assigned to Arm(s): Intervention Group
B: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention
C: Arm Label: Passive SMS Group; Type: ACTIVE_COMPARATOR; Interventions: Other: SMS text messaging | Arm Label: Active SMS Group; Type: EXPERIMENTAL; Interventions: Other: SMS text messaging | Intervention Type: OTHER; Name: SMS text messaging; Assigned to Arm(s): Active SMS Group, Passive SMS Group
D: Arm Label: Novel integrated care concept (NICC); Type: EXPERIMENTAL; Interventions: Other: Novel integrated care concept (NICC) | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Novel integrated care concept (NICC); Assigned to Arm(s): Novel integrated care concept (NICC) | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction
Brief Summary: The computerized cognitive rehabilitation therapy will be used to treat amphetamine-type stimulant (ATS) addiction.


Options:
A: Arm Label: Standard of Care (SOC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care | Arm Label: Behavioral Activation & Risk Reduction Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: IMPACT | Intervention Type: BEHAVIORAL; Name: IMPACT; Assigned to Arm(s): Behavioral Activation & Risk Reduction Counseling | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard of Care (SOC)
B: Arm Label: cognitive function rehabilitation group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: cognitive bias modification group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cognitive function rehabilitation and bias modification; Assigned to Arm(s): cognitive bias modification group, cognitive function rehabilitation group
C: Arm Label: Standard treatment Alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard treatment | Arm Label: ST+CM; Type: EXPERIMENTAL; Interventions: Behavioral: ST+CM | Intervention Type: BEHAVIORAL; Name: ST+CM; Assigned to Arm(s): ST+CM | Intervention Type: BEHAVIORAL; Name: standard treatment; Assigned to Arm(s): Standard treatment Alone
D: Arm Label: ARTEMIS+CM; Type: EXPERIMENTAL; Interventions: Behavioral: Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS), Behavioral: Contingency Management (CM) | Arm Label: Attention-Control+CM; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Contingency Management (CM) | Intervention Type: BEHAVIORAL; Name: Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS); Assigned to Arm(s): ARTEMIS+CM | Intervention Type: BEHAVIORAL; Name: Contingency Management (CM); Assigned to Arm(s): ARTEMIS+CM, Attention-Control+CM

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Severity of Co-morbidity on Outcomes of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients
Brief Summary: Our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes.


Options:
A: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)
B: Arm Label: Low Comorbidity Index Score; Type: OTHER; Interventions: Other: Exercise | Arm Label: High Comorbidity Index Score; Type: OTHER; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): High Comorbidity Index Score, Low Comorbidity Index Score
C: Arm Label: Tiotropium low; Type: EXPERIMENTAL; Interventions: Drug: Tiotropium low | Arm Label: Tiotropium medium; Type: EXPERIMENTAL; Interventions: Drug: Tiotropium medium | Arm Label: Tiotropium high; Type: EXPERIMENTAL; Interventions: Drug: Tiotropium high | Arm Label: Tiotropium 18mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium 18mcg | Arm Label: Tiotropium placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Tiotropium placebo | Intervention Type: DRUG; Name: Tiotropium medium; Assigned to Arm(s): Tiotropium medium | Intervention Type: DRUG; Name: Tiotropium low; Assigned to Arm(s): Tiotropium low | Intervention Type: DRUG; Name: Tiotropium high; Assigned to Arm(s): Tiotropium high | Intervention Type: DRUG; Name: Tiotropium 18mcg; Assigned to Arm(s): Tiotropium 18mcg | Intervention Type: DRUG; Name: Tiotropium placebo; Assigned to Arm(s): Tiotropium placebo
D: Arm Label: Telemonitoring (Medly); Type: EXPERIMENTAL; Interventions: Device: Medly | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Medly; Assigned to Arm(s): Telemonitoring (Medly)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Randomized Multicenter Study to Demonstrate the Benefits of Hemodialysis Without Acetate (With Citrate): ABC-treat Study
Brief Summary: Prospective randomized cross-over multicenter study to demonstrate the benefits of hemodialysis without acetate dialysate, with citrate.

32 weeks duration, in two phases. In the first, half of the patients started with citrate dialysate for 16 weeks and the other half with acetate dialysate, and then patients cross.

The primary objective is to analyze the effect of citrate dialysate on acid base balance decreasing chronic metabolic acidosis and avoiding / reducing post-dialytic alkalosis.


Options:
A: Arm Label: Apixaban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apixaban | Arm Label: Vitamin-K antagonists (Phenprocoumon); Type: ACTIVE_COMPARATOR; Interventions: Drug: Phenprocoumon | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): Apixaban | Intervention Type: DRUG; Name: Phenprocoumon; Assigned to Arm(s): Vitamin-K antagonists (Phenprocoumon)
B: Arm Label: saline flushes; Type: PLACEBO_COMPARATOR; Interventions: Drug: two stage regional citrate | Arm Label: one stage regional citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: one stage regional citrate | Arm Label: two stage regional citrate; Type: EXPERIMENTAL; Interventions: Drug: two stage regional citrate, Drug: one stage regional citrate | Intervention Type: DRUG; Name: two stage regional citrate; Assigned to Arm(s): saline flushes, two stage regional citrate | Intervention Type: DRUG; Name: one stage regional citrate; Assigned to Arm(s): one stage regional citrate, two stage regional citrate
C: Arm Label: PMMA (BKU); Type: ACTIVE_COMPARATOR; Interventions: Device: PMMA (BKU) | Arm Label: PS (Phylter); Type: ACTIVE_COMPARATOR; Interventions: Device: PS (Phylter) | Arm Label: AN69ST (Evodial); Type: ACTIVE_COMPARATOR; Interventions: Device: AN69ST (Evodial) | Intervention Type: DEVICE; Name: PMMA (BKU); Assigned to Arm(s): PMMA (BKU) | Intervention Type: DEVICE; Name: PS (Phylter); Assigned to Arm(s): PS (Phylter) | Intervention Type: DEVICE; Name: AN69ST (Evodial); Assigned to Arm(s): AN69ST (Evodial)
D: Arm Label: Citrate dialysate; Type: ACTIVE_COMPARATOR; Interventions: Other: Citrate dialysate | Arm Label: Acetate dialysate; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Citrate dialysate; Assigned to Arm(s): Citrate dialysate

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Commercial Mobile Apps for Weight Management be Used in Interventions? Bridging the Gap Between Usability, Theoretical Adherence, and User Experience - Part II - WaznApp Trial
Brief Summary: WaznApp study is a 12-week randomized controlled trial aimed to evaluate the feasibility and preliminary efficacy of a self-directed behavioral weight-loss intervention targeting employees of an academic institution, using two popular consumer mobile applications for weight loss. The hypothesis is that individuals assigned to the app that provides interactive feedback and proactively motivates engagement in healthy behaviors (eating healthily and being more active) will be significantly better than those who receive the comparison condition (a simple calorie tracking app).


Options:
A: Arm Label: Lark (JITAI); Type: EXPERIMENTAL; Interventions: Combination Product: Lark (JITAI) | Arm Label: MyFitnessPal (no JITAI); Type: ACTIVE_COMPARATOR; Interventions: Combination Product: MyFitnessPal (no JITAI) | Intervention Type: COMBINATION_PRODUCT; Name: Lark (JITAI); Assigned to Arm(s): Lark (JITAI) | Intervention Type: COMBINATION_PRODUCT; Name: MyFitnessPal (no JITAI); Assigned to Arm(s): MyFitnessPal (no JITAI)
B: Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Arm Label: Technology Supported condition; Type: EXPERIMENTAL; Interventions: Behavioral: Technology Supported | Arm Label: Self-Guided; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Technology Supported; Assigned to Arm(s): Technology Supported condition | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: smartcare; Type: ACTIVE_COMPARATOR; Interventions: Device: smartcare | Arm Label: smartcare plus financial incentives; Type: ACTIVE_COMPARATOR; Interventions: Device: smartcare, Other: financial incentives | Intervention Type: DEVICE; Name: smartcare; Assigned to Arm(s): smartcare, smartcare plus financial incentives | Intervention Type: OTHER; Name: financial incentives; Assigned to Arm(s): smartcare plus financial incentives
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone + Text Messaging with Health Coach | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Smartphone + Text Messaging with Health Coach; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vacuum Myofascial Therapy Device for Non-specific Neck Pain. A Single Blind Randomized Clinical Trial
Brief Summary: This study aim to investigate the effects of physium therapy for improving pressure pain thresholds (PPTs), range of motion,Neck Disability Index, the multidimensional health related quality of life (SF-12) and the multidimensional health related quality of life and pain in patients with mechanical neck pain (NP).


Options:
A: Arm Label: EXPERIMENTAL GROUP; Type: EXPERIMENTAL; Interventions: Procedure: Physiotherapy treatment with physium device. | Arm Label: CONTROL GROUP; Type: EXPERIMENTAL; Interventions: Procedure: Conventional physiotherapy treatmen | Intervention Type: PROCEDURE; Name: Physiotherapy treatment with physium device.; Assigned to Arm(s): EXPERIMENTAL GROUP | Intervention Type: PROCEDURE; Name: Conventional physiotherapy treatmen; Assigned to Arm(s): CONTROL GROUP
B: Arm Label: Study Group; Type: EXPERIMENTAL; Interventions: Other: Mulligan Mobilization for Study Group | Arm Label: Control Group; Type: OTHER; Interventions: Other: Conventional therapy for Control Group | Intervention Type: OTHER; Name: Mulligan Mobilization for Study Group; Assigned to Arm(s): Study Group | Intervention Type: OTHER; Name: Conventional therapy for Control Group; Assigned to Arm(s): Control Group
C: Arm Label: Group I Experimental: thoracic manipulation; Type: EXPERIMENTAL; Interventions: Other: Thoracic manipulation | Arm Label: Group II Control; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional pt protocol | Intervention Type: OTHER; Name: Thoracic manipulation; Assigned to Arm(s): Group I Experimental: thoracic manipulation | Intervention Type: OTHER; Name: conventional pt protocol; Assigned to Arm(s): Group II Control
D: Arm Label: Craniosacral Therapy (CST); Type: EXPERIMENTAL; Interventions: Procedure: Craniosacral Therapy | Arm Label: Sham Craniosacral Therapy (SHAM); Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Craniosacral Therapy | Intervention Type: PROCEDURE; Name: Craniosacral Therapy; Assigned to Arm(s): Craniosacral Therapy (CST) | Intervention Type: PROCEDURE; Name: Sham Craniosacral Therapy; Assigned to Arm(s): Sham Craniosacral Therapy (SHAM)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Whole Body Vibration and Pelvic Floor Muscle Exercises in Treating Urinary Incontinence Following Prostate Cancer Surgery: A Comparative Randomized Controlled Trial
Brief Summary: Stress urinary incontinence is common in men following prostate cancer surgery. Rehabilitative interventions incorporate pelvic floor muscle training, biofeedback, electrical stimulation, lifestyle changes, or a combination of these strategies. However, little is known about the physiological impact of whole-body vibration for stress urinary incontinence following radical prostatectomy. Participants: Sixty-one patients with mild Stress urinary incontinence after radical prostatectomy.

Intervention: patients were randomly assigned into two groups: group 1 included 30 patients who received pelvic floor muscle training and whole-body vibration training with a frequency and amplitude of 20 Hz/ 2 mm for the first 2 sessions and 40 Hz/ 4 mm for the rest of intervention; while group 2 included 31 patients who performed only pelvic floor muscle training. The intervention in both groups was performed three times per week for 4 weeks.


Options:
A: Arm Label: study group; Type: ACTIVE_COMPARATOR; Interventions: Other: whole body vibration | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: whole body vibration; Assigned to Arm(s): study group
B: Arm Label: Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Behavioral Therapy Plus Technologies; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy, Device: Pelvic Floor Electrical Stimulation, Behavioral: Biofeedback | Arm Label: Placebo Comparator; Type: PLACEBO_COMPARATOR; Interventions: Other: No Treatment | Intervention Type: BEHAVIORAL; Name: Behavioral Therapy; Assigned to Arm(s): Behavioral Therapy, Behavioral Therapy Plus Technologies | Intervention Type: DEVICE; Name: Pelvic Floor Electrical Stimulation; Assigned to Arm(s): Behavioral Therapy Plus Technologies | Intervention Type: BEHAVIORAL; Name: Biofeedback; Assigned to Arm(s): Behavioral Therapy Plus Technologies | Intervention Type: OTHER; Name: No Treatment; Assigned to Arm(s): Placebo Comparator
C: Arm Label: Kegel exercise education; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Extracorporeal biofeedback device; Type: EXPERIMENTAL; Interventions: Device: Extracorporeal biofeedback device (Any Kegel) | Intervention Type: DEVICE; Name: Extracorporeal biofeedback device (Any Kegel); Assigned to Arm(s): Extracorporeal biofeedback device
D: Arm Label: PILATES; Type: EXPERIMENTAL; Interventions: Other: Pilates | Arm Label: PFMT and AES; Type: ACTIVE_COMPARATOR; Interventions: Other: PFMT and AES | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Pilates; Assigned to Arm(s): PILATES | Intervention Type: OTHER; Name: PFMT and AES; Assigned to Arm(s): PFMT and AES | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: A